|Bid||56.20 x 300|
|Ask||56.23 x 100|
|Day's Range||55.80 - 56.21|
|52 Week Range||40.73 - 56.42|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.60%|
On December 18, 2017, Westlake Chemical (WLK) announced that it had sent notices about the optional redemption of $688 million in senior notes.
After Priceline (PCLN) released its 3Q17 results, analysts’ estimates for 2017 and 2018 were revised downwards. For the fourth quarter of 2017, sales are expected to grow 14.8% year-over-year or YoY to ...
A large part of Priceline’s (PCLN) growth in the past has come from acquiring smaller companies all over the world. It had to raise debt to finance some of these acquisitions.
Analysts expect Priceline's fiscal 2017 revenues to grow 16.7% YoY to $12.5 billion, which is slightly lower than the 16.5% YoY growth seen in 2016.
On October 4, 2017, H.B. Fuller (FUL) announced that Ruth Kimmelshue had been appointed to the company's board of directors, effective immediately.
Celanese stock fell 1.0% and closed at $95.77. Despite the fall in the prices, the stock was trading 4.3% above the 100-day moving average price of $91.78.
On August 2, 2017, Celanese (CE) announced that it's increasing the prices of a few acetyl intermediates. The price increase will be effective immediately.
Investors have heard quite a bit of this lately: The energy sector is the worst-performing group in the S&P 500. However, the struggles of the S&P 500's seventh-largest sector weight are not uniform — ...
Todd Rosenbluth is director of ETF and mutual fund research at CFRA. As earnings season kicks off, investors will be closely watching the U.S. technology sector. Expectations for strong results are high. However, ETF investors will want to understand the industry-exposure differences of products they own or are considering owning, since not all tech companies have the same fundamentals.
The value factor is again receiving increased attention, but it was not particularly exhilarating for investors in the first quarter of 2017. And with volatility relatively benign, the low volatility and ...